期刊文献+

精神分裂症迟发性运动障碍患者血糖水平分析 被引量:2

Blood glucose levels in schizophrenics with tardive dyskinesia
暂未订购
导出
摘要 目的探讨精神分裂症迟发性运动障碍患者的血糖代谢水平。方法对30例精神分裂症迟发性运动障碍患者与30例精神分裂症非迟发性运动障碍患者和30例性别、年龄与患者匹配的正常健康体检者的空腹血糖水平进行测定分析。结果精神分裂症迟发性运动障碍患者血糖水平均显著低于精神分裂症非迟发性运动障碍患者和正常对照组(t=9.859、9.879,P均<0.01);而精神分裂症非迟发性运动障碍患者与正常对照组比较无显著性差异(t=0.031,P>0.05)。结论精神分裂症迟发性运动障碍患者血糖水平显著降低,在临床治疗中应引起重视。 Objective To explore the metabolic levels of blood glucose in schizophrenics with tardive dyskinesia(TD). Methods Fasting blood-glucose levels were determined and analyzed in 30 TD shizophrenics , 30 non-TD ones and 30 healthy adults matched gender and age. Results Fasting blood-glucose levels were significantly lower of TD shizophrenics than of both non-TD ones and normal control (both P〈 0.01) ; there was no significant difference between non-TD shizophrenics and normal control(P〉0.05). Conclusion Blood glucose levels in schizophrenics with TD lower significantly and should be placed emphasis on clinically.
作者 付云婕
出处 《临床心身疾病杂志》 CAS 2008年第5期396-397,共2页 Journal of Clinical Psychosomatic Diseases
关键词 精神分裂症 迟发性运动障碍 血糖 药源性 Schizophrenia tardive dyskinesia blood glucose drug-induced
  • 相关文献

参考文献7

  • 1中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M].济南:山东科学技术出版社,2001.87-90.
  • 2Schooler NR, Kane JM. Research diagnosis for tardive dyskinesia(letter) [J]. Arch Gen Psychiatry, 1982,39 : 486.
  • 3樊彬.不自主运动评定量表(AIMS).上海精神医学,1990,2:65-65.
  • 4Baldessarini RJ. Dissimilar dosing with high-potency and low potency neuroleptics[J ]. Am J Psychiatry, 1984,141 : 748.
  • 5唐英,张小钱,周家红,袁德胜.迟发性运动障碍与糖代谢关系探讨[J].临床精神医学杂志,2000,10(2):106-106. 被引量:1
  • 6王祖新,裴印权,金有豫.临床精神药理学[M].第1版.北京:北京医科大学中国协和医科大学联合出版社,1990:134.
  • 7刘铁榜,藏德馨.精神分裂症生物学研究进展[M].武汉:湖北科技出版社,1994:294-309.

二级参考文献2

共引文献219

同被引文献28

  • 1胡隆珊,魏庆平.维生素E治疗迟发性运动障碍2例[J].中原精神医学杂志,1996,2(4):233-234. 被引量:1
  • 2孙振晓,姚传文.精神分裂症迟发性运动障碍患者血清肌酸激酶水平的研究[J].中国神经精神疾病杂志,2005,31(2):140-141. 被引量:7
  • 3曾昭祥,李志成,于兴旺,张永东,曹中昌.氟苯桂嗪治疗迟发性运动障碍的双盲自身对照试验[J].药物流行病学杂志,1994,3(4):183-184. 被引量:5
  • 4Steketee JD. Neurotransmitter systems of the medial prefrontal cortex potential role in sensitization to psychos- timulants[J. Brain Res Brain Res Rev, 2003,41 ( 2 - 3) : 203.
  • 5Horvdth ZC, Czopf J, Buzsaki G. MK-801-induced neu- ronal damage in ratsrJ. Brain Res, 1997,753(2) : 181.
  • 6Fachinetto R, Villarinho JG, Wagner C, et al. Valeri- ana officials does not alter the orofacial dyskinesia induced by haloperidol in rats: rote of dopamine transporter [J. Prog Neuropsychopharmacol Biol Psychiatry, 2007,31 (7) : 1478.
  • 7Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia[-J]. Arch Gen Psychiatry,1982,39(2) :486.
  • 8Konradic C, Honradi S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treat- ment[-J. Pharmacol Ther,2003,97(2) . 153.
  • 9Altamura CA, Mauri MC, Ferrara A, et al. Plasma and platelet excitatory amino acids in psychiatric disorders [-J. Am J psychiatry,1993,150(ll) :1731.
  • 10Ross DE,Thomas M,Booth M. Rate of tardive dyskinesia in hospitailized patients[J].American Journal of Psychiatry,2005,(04):816.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部